BioNanoScience, Journal Year: 2024, Volume and Issue: 15(1)
Published: Dec. 6, 2024
Language: Английский
BioNanoScience, Journal Year: 2024, Volume and Issue: 15(1)
Published: Dec. 6, 2024
Language: Английский
Pharmaceutics, Journal Year: 2024, Volume and Issue: 16(6), P. 761 - 761
Published: June 4, 2024
Natural compounds such as polyphenols play several positive roles in maintaining the oxidative and inflammatory capacity of cells, which leads to their potential use anticancer therapeutics. There is promising evidence for vitro vivo activity many polyphenols, including resveratrol quercetin, specifically treatment colorectal cancer (CRC). a clear association between quercetin interfering with mechanistic pathways involved CRC, Wnt, P13K/AKT, caspase-3, MAPK, NF-κB, etc. These molecular establish role controlling cell growth, inducing apoptosis, inhibiting metastasis. The major bottleneck progression therapeutics reduced bioavailability because rapid metabolism humans. Recent advancements various nanotechnological formulations are overcoming these issues. Various nanoformulations have shown an optimistic impact on reducing solubility improving stability vivo. A combinatorial approach using could potentially increase CRC proliferation. This review discusses mechanism two bioactive polyphenolics, colon cancer, emphasis types molecules targeting cancer. It also explores synergistic effect combining nanoformulations, research delves into enhanced pharmacokinetics chemotherapeutic benefits polyphenolics when used together innovative ways.
Language: Английский
Citations
10BioNanoScience, Journal Year: 2025, Volume and Issue: 15(2)
Published: Feb. 3, 2025
Language: Английский
Citations
1Assay and Drug Development Technologies, Journal Year: 2025, Volume and Issue: unknown
Published: Jan. 8, 2025
Language: Английский
Citations
0BioNanoScience, Journal Year: 2025, Volume and Issue: 15(1)
Published: Jan. 17, 2025
Language: Английский
Citations
0Journal of Drug Delivery Science and Technology, Journal Year: 2025, Volume and Issue: unknown, P. 106685 - 106685
Published: Feb. 1, 2025
Language: Английский
Citations
0Prospects in Pharmaceutical Sciences, Journal Year: 2025, Volume and Issue: 23(1), P. 102 - 110
Published: March 1, 2025
The design and development of invasomes containing bifonazole for effective topical fungal treatment was investigated to improve the bioavailability therapeutic efficacy this antifungal agent. Invasomes, novel lipid-based vesicular systems, were formulated enhance skin penetration provide sustained drug release, thereby increasing local concentration at site infection. formulation optimized using response surface methodology (RSM), where various factors such as phosphatidylcholine, terpenes, ethanol varied evaluate their effects on entrapment efficiency, vesicle size, release characteristics. invasomal demonstrated high efficiency (~74.12%) an average size 154.45 nm, suitable penetration. In vitro studies revealed from invasomes, with a slower profile compared plain drug. exhibited enhanced activity, suggesting that could serve promising carrier delivery bifonazole, offering potential solution treating superficial infections improved patient compliance.
Language: Английский
Citations
0Gels, Journal Year: 2025, Volume and Issue: 11(4), P. 245 - 245
Published: March 26, 2025
Dermatological diseases pose a significant challenge due to their chronic nature, complex pathophysiology, and the need for effective, patient-friendly treatments. Recent advancements in liposomal gel-based formulations have played crucial role improving drug delivery, therapeutic efficacy, patient compliance. Liposomal garnered considerable attention dermatology ability encapsulate both hydrophilic lipophilic compounds, enabling controlled release enhanced skin penetration. However, challenges such as formulation complexity, stability issues, regulatory constraints remain. Similarly, are widely used ease of application, biocompatibility, retain active ingredients. they also face limitations, including restricted penetration depth, susceptibility microbial contamination, achieving sustained release. The integration technologies offers promising strategy overcome current optimize dermatological delivery. This review explores well-established therapies recent innovations, offering comprehensive overview applications treatment prevalent conditions. Ultimately, continued research is essential refine these formulations, expanding clinical utility enhancing effectiveness dermatology.
Language: Английский
Citations
0Elsevier eBooks, Journal Year: 2025, Volume and Issue: unknown, P. 141 - 176
Published: Jan. 1, 2025
Language: Английский
Citations
0International Journal of Pharmaceutics, Journal Year: 2025, Volume and Issue: 677, P. 125639 - 125639
Published: April 24, 2025
Language: Английский
Citations
0International Journal of Pharmaceutics, Journal Year: 2024, Volume and Issue: unknown, P. 124731 - 124731
Published: Sept. 1, 2024
Language: Английский
Citations
3